Cardiovascular Therapeutics (Jan 2024)
Cysteine Leukotriene Receptor Antagonist—Montelukast—Treatment Improves Experimental Abdominal Aortic Aneurysms in Mice
Abstract
Conclusion: Montelukast treatment improves experimental nondissected AAAs in mice partly by improving aortic inflammation.